SARS-CoV-2 infection in free-ranging white-tailed deer - Nature

México Noticias Noticias

SARS-CoV-2 infection in free-ranging white-tailed deer - Nature
México Últimas Noticias,México Titulares
  • 📰 Nature
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 68%

A paper in Nature shows that white-tailed deer are a reservoir for SARS-CoV-2 in North America

Present address: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USAVeterinary Preventive Medicine, The Ohio State University College of Veterinary Medicine, Columbus, OH, 43210, USA

Vanessa L. Hale, Patricia M. Dennis, Dillon S. McBride, Jaqueline M. Nolting, Christopher Madden, Devra Huey, Linda Saif & Andrew S.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Nature /  🏆 64. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19A new Science study details PF-07321332, an orally active, small-molecule inhibitor of the SARSCoV2 main protease, a key viral target. In a phase I clinical trial, it achieved concentrations expected to inhibit the virus based on in vitro studies. pfizer
Leer más »

A new tool to probe SARS-CoV-2 variantsA new tool to probe SARS-CoV-2 variantsVirus-like particles offer a new way to investigate genetic variation in SARSCoV2. Learn more in a new SciencePerspective:
Leer más »

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftNature research paper: Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Leer más »

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftNature research paper: Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Leer más »

A new tool to probe SARS-CoV-2 variantsA new tool to probe SARS-CoV-2 variantsVirus-like particles offer a new way to investigate genetic variation in SARSCoV2. Learn more in a new SciencePerspective:
Leer más »

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19A new Science study details PF-07321332, an orally active, small-molecule inhibitor of the SARSCoV2 main protease, a key viral target. In a phase I clinical trial, it achieved concentrations expected to inhibit the virus based on in vitro studies. pfizer
Leer más »



Render Time: 2025-04-03 06:08:25